Media
Investors
Careers
About Roche
About Roche
Strategy
Business
Sustainability
Leadership
Governance
History
Solutions
Solutions
Focus areas
Pharma solutions
Diagnostics solutions
Pipeline
Innovation
Innovation
Team & structure
Innovation process
Ethical standards
Partnering
Stories
Investors
IR Events
Roche’s live audio webcast and conference call from ESMO IO 2017
Please register to access the replay*
*Privacy notice
Check out the
replay here
First Name
Last name
Corporate Email
Company Name
Job Role
Please select
Buy-Side Analyst and Fund Manager
Private Banking and Retail Banking
Private Investor and others
Sell-Side Analyst
Other
Country/Region
Afghanistan
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigue and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia
Botswana
Bouvet Island
Brazil
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Côte d'Ivoire
Cambodia
Cameroon
Canada
Cap Verde
Caribe, Centroamerica
Cayman Islands
Central African Rep.
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, Democratic Republic
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibuti
Dominica
Dominican republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guyana
French Polynesia
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Holy See (Vatican City State)
Honduras
Hong Kong (SAR), China
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic
Kosovo
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macau (SAR), China
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestine
Panamá
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
São Tomé and Príncipe
Saint Barthelemy
Saint Helena, Ascension and Tristan da Cunha
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the south Sandwich Islands
South Korea
Spain
Sri Lanka
Sudan
Suriname
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
USA
Uganda
Ukraine
Union of Myanmar
United Arab Emirates
United Kingdom
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands, British
Virgin Islands, US
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Confirm you are a human *
The test requires you to consent to targeting cookies
Submit
Clear filter
Agenda:
IMpower150: Phase 3 results of carboplatin + paclitaxel +/- Avastin, with or without Tecentriq in 1L non-squamous metastatic NSCLC
Tecentriq program overview: Focusing on novel combination approaches
Alan Sandler, M.D., Global Development Team Leader Tecentriq Lung
Cathi Ahearn, Global Product Strategy Tecentriq
Investors
Past IR Events
View more Events
Downloads
ESMO IO IMpower150
PDF
Investor presentation
PDF
Related links